Skip to content
initiative Octalfa
Engagés pour l'innovation et la santé
initiative Octalfa
  • Home
  • About us
  • Our history
  • Our team
  • Newsroom
  • Contact
  • French
  • Home
  • About us
  • Our history
  • Our team
  • Newsroom
  • Contact
  • French

14 October 2020

You are here:
  1. Home
  2. 2020
  3. October
  4. 14

Amolyt Pharma Doses First Subject in Phase 1 Clinical Trial of Parathyroid Hormone Analog AZP-3601

UncategorizedBy Charlotte Maddalena14 October 2020
Go to Top